Amgen (AMGN) Copletes Mustafa Nevzat Pharma Acquisition

Amgen (Nasdaq: AMGN) announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals, a privately held Turkish company. The all-cash transaction significantly expands Amgen's presence in Turkey and the surrounding region, which includes several fast-growing, priority markets for Amgen. The acquisition was initially announced on April 25.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FTC files amicus brief challenging Amgen's Enbrel patent acquisition
• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Amgen (AMGN) PT Raised to $460 at Argus